Methylated free-circulating HPP1 DNA is an early response marker in patients with metastatic colorectal cancer.

about

Liquid biopsies in gastrointestinal malignancies: when is the big day?Pharmacoepigenetics and pharmacoepigenomics of gastrointestinal cancers.Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review.

P2860

Q47372761-6BF85B63-7464-4E44-B9F4-9C0090B1C82C Q50252299-32081D13-7120-4BBD-883F-2B63B1D1E34E Q52802632-92A6943C-D15B-4765-9109-33E7FDD91992

P2860

Methylated free-circulating HPP1 DNA is an early response marker in patients with metastatic colorectal cancer.

Item

http://www.wikidata.org/entity/Q40363878

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Methylated free-circulating HP ...... metastatic colorectal cancer.

@en

type

Item

label

Methylated free-circulating HP ...... metastatic colorectal cancer.

@en

prefLabel

Methylated free-circulating HP ...... metastatic colorectal cancer.

@en

P1476

Methylated free-circulating HP ...... h metastatic colorectal cancer

@en

P2093

Andrea Ofner

http://www.w3.org/2001/XMLSchema#string

Andreas Herbst

http://www.w3.org/2001/XMLSchema#string

Dirk Arnold

http://www.w3.org/2001/XMLSchema#string

Dorothea Nagel

http://www.w3.org/2001/XMLSchema#string

Frank T Kolligs

http://www.w3.org/2001/XMLSchema#string

Ingrid Ricard

http://www.w3.org/2001/XMLSchema#string

Lesca M Holdt

http://www.w3.org/2001/XMLSchema#string

Mark Op den Winkel

http://www.w3.org/2001/XMLSchema#string

Nikolay Vdovin

http://www.w3.org/2001/XMLSchema#string

Petra Stieber

http://www.w3.org/2001/XMLSchema#string

P2860

MethyLight: a high-throughput assay to measure DNA methylation

HPP1: a transmembrane protein-encoding gene commonly methylated in colorectal polyps and cancers

CpG island methylator phenotype in colorectal cancer

Extended RAS analysis for anti-epidermal growth factor therapy in patients with metastatic colorectal cancer

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer

Analysis of circulating tumor DNA to monitor metastatic breast cancer

Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA

Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial.

P304

2134-2144

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.30625

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

140

http://www.w3.org/2001/XMLSchema#string

P50

Dirk Arnold

Alexander B Philipp

P577

2017-02-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28124380

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

Methylated free-circulating HPP1 DNA is an early response marker in patients with metastatic colorectal cancer.

about

P2860

P2860

Methylated free-circulating HPP1 DNA is an early response marker in patients with metastatic colorectal cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921